size of 5 mm
location at the lower calyx
density of 400 HU
being recurrent
B. location at the lower calyx
upper, lower, mid
lower, upper, mid
mid, upper, lower
mid, lower, upper
a stone in the lower calyx with a wide mouth of infundibulum and obtuse lower calyx to ureter angle
a stone in an anterior group calyceal diverticulum with thin overlying renal parenchyma
5 mm calcium-containing stone in an intrarenal pelvis and wide UPJ
6 years post anatrophic nephrolithotomy, recurrent mid calyceal stone
ciprofloxacin
indinavir
thiazides
triamterene
they are mandatory when urine shows ≥ 10 WBCs/hpf in symptomatic patients
they aim at treating pyonephrosis and urosepsis
they should cover Escherichia coli and Staphylococcus, Enterobacter, Proteus, and Klebsiella species
All of the above
formation of triple-phosphate stones
infection with Proteus species
increase production of endogenous uric acid
increase level of uric acid in THE blood
blood cells more than pus cells
pus cells if infection was superadded
crystals might appear
all of the above
Ca.oxalate, Ca.phosphate, Na.urate, cystine
Ca.phosphate, Ca.oxalate, cystine, Na.urate
Ca.oxalate, Ca.phosphate, cystine, Na.urate
Ca.phosphate, Ca.oxalate, Na.urate, cystine
transitional epithelium lining minor calyces
transitional epithelium lining major calyces
basement membrane of the loops of Henle
papillary tips of polar pyramids
≥ 2 cm diameter
upper calyx location
Na.urate composition
600 - 800 HU density
localization of stones in the ureter is difficult or impossible
inability to visualize stones breaking down in real time
c. patient`s position on ESWL table is uncomfortable
d. inability to visualize radiolucent stones
frequently caused by loop diuretics
stones are often radiolucent
may be reversed by the use of thiazides
low calcium-to-creatinine ratio predicts stones resolution
Ca.phosphate
Ca.oxalate
Na.urate
struvite
is symptomless
should undergo a trial of milking out
diverticulectomy and stone extraction is the treatment of choice
ESWL is the preferred treatment option
the surface area of the stones
the volume of the stones
the density of the stones
the number of the stones
ammonium urate
sodium urate
calcium oxalate
calcium phosphate
anterior lower pole calyx
posterior lower pole calyx
anterior upper pole calyx
posterior upper pole calyx
commonly unilateral
commonly due to repeated infections
urate stones are the second most common cause of staghorn calculi
ESWL monotherapy with ureteral stenting is the ideal treatment
impaired renal tubular calcium reabsorption
excessive glomerular leak of calcium
deficiency of the enzyme xanthine oxidase
hypercalcemia
classical nucleation theory
heterogeneous nucleation
suspension solution
concentric lamination
cysteine
urate
calcium
none of the above
ESWL
PCNL
radial nephrolithotomy
pyelolithotomy with ureteral stenting
increase urinary calcium, oxalate, and uric acid excretion
decrease urinary calcium; but increase oxalate, and uric acid excretion
increased urinary calcium and uric acid; but decrease oxalate excretion
decreased urinary calcium, oxalate, and uric acid excretion
uncontrollable bleeding
incomplete removal of stones
pneumothorax
colonic perforation
cystine
brushite
Ca.oxalate monohydrate
Ca.oxalate dihydrate
stone chemical composition
stone burden
first stone vs. recurrent
stone density
limit beef, chicken, pork, eggs, fish, shellfish, and other animal proteins
limit beans, nuts, chocolate, coffee, dark green vegetables, and soda
limit canned, packaged, and fast foods
limit milk, cheese, and other dairy products
matrix
indinavir
brushite
2,8 dihydroxyadenine
by lowering urinary saturation of Ca.oxalate
by preventing heterogeneous nucleation of Ca.oxalate
by inhibiting spontaneous precipitation and agglomeration of Ca.oxalate
by all of the above
2 days
2 weeks
2 months
4 6 hrs.
Kock pouch
Neobladder-to-urethra diversion
Florida pouch
Indiana pouch